| Jon C Gaudio, MD | |
|
196 Parkway South, Suite 103, Waterford, CT 06385 | |
| (860) 443-4383 | |
| (860) 448-6797 |
| Full Name | Jon C Gaudio |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 29 Years |
| Location | 196 Parkway South, Waterford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205885258 | NPI | - | NPPES |
| 06-1616101 | Other | UNITEDHEALTHCARE/ECCD | |
| 06-1616101 | Other | COMM. HEALTH NETWORK/ECCD | |
| 010040569CT01 | Other | ANTHEM/ECCG:06-1049086 | |
| P2680050 | Other | OXFORD/ECCG: 06-1049086 | |
| 010040569CT03 | Other | ANTHEM/ECCD:06-1616101 | |
| 2V2262 | Other | HEALTHNET/ECCD:06-1616101 | |
| 040569 | Other | CONNECTICARE | |
| 06-1049086 | Other | COMM. HEALTH NETWORK/ECCG | |
| 06-1049086 | Other | UNITEDHEALTHCARE/ECCG | |
| 060070007 | Other | RR MED/ECCD: 06-1616101 | |
| P3615266 | Other | OXFORD/ECCD: 06-1616101 | |
| 001405697 | Medicaid | CT | |
| 060069422 | Other | RR MED/ECCG: 06-1049086 | |
| 001405697 | Other | BLUECARE FAMILY PLAN | |
| 2V2256 | Other | HEALTHNET/ECCG:06-1049086 | |
| 500HBC444CT01 | Other | ANTHEM/HOSP-BASED ECCD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 40569 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Westerly Hospital | Westerly, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg).
"Tonight's historic vote marks a major milestone in the struggle to break the power of the insurance industry and provide quality, affordable health care for millions of American families. Democrats in the House, with the determined leadership of President Barack Obama and Speaker Nancy Pelosi, demonstrated the courage that is necessary to defeat the special interests and do what is right for the American people.
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
The Scripps Research Institute has been awarded $3.17 million over four years to develop compounds that will counteract disruptions of the human biological clock - the circadian rhythm that regulates our patterns of activity and rest over a 24-hour daily cycle.
› Verified 2 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg).
"Tonight's historic vote marks a major milestone in the struggle to break the power of the insurance industry and provide quality, affordable health care for millions of American families. Democrats in the House, with the determined leadership of President Barack Obama and Speaker Nancy Pelosi, demonstrated the courage that is necessary to defeat the special interests and do what is right for the American people.
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
The Scripps Research Institute has been awarded $3.17 million over four years to develop compounds that will counteract disruptions of the human biological clock - the circadian rhythm that regulates our patterns of activity and rest over a 24-hour daily cycle.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jon C Gaudio, MD 481 Gold Star Hwy, Suite 101, Groton, CT 06340-6224 Ph: () - | Jon C Gaudio, MD 196 Parkway South, Suite 103, Waterford, CT 06385 Ph: (860) 443-4383 |
News Archive
The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg).
"Tonight's historic vote marks a major milestone in the struggle to break the power of the insurance industry and provide quality, affordable health care for millions of American families. Democrats in the House, with the determined leadership of President Barack Obama and Speaker Nancy Pelosi, demonstrated the courage that is necessary to defeat the special interests and do what is right for the American people.
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
The Scripps Research Institute has been awarded $3.17 million over four years to develop compounds that will counteract disruptions of the human biological clock - the circadian rhythm that regulates our patterns of activity and rest over a 24-hour daily cycle.
› Verified 2 days ago
Christi Young-ah Kim, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 230 Waterford Pkwy S, Waterford, CT 06385 Phone: 860-444-3744 Fax: 860-271-4947 | |
Meghana Rao Brito, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 196 Waterford Pkwy S Ste 103, Waterford, CT 06385 Phone: 860-443-4383 | |
Dr. Mithlesh Govil, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 196 Parkway S, Suite 303, Waterford, CT 06385 Phone: 860-443-4455 Fax: 860-447-8961 | |
Mark N Fiengo, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 196 Parkway S, Suite 103, Waterford, CT 06385 Phone: 860-443-4383 Fax: 860-443-3980 | |
Mark Somers, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 196 Parkway South, Suite 103, Waterford, CT 06385 Phone: 860-443-4383 Fax: 860-443-3980 | |
Benjamin R Newton, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 230 Waterford Parkway South, Suite 201, Waterford, CT 06385 Phone: 860-444-3744 Fax: 860-271-4457 |